IOL Chemicals and Pharmaceuticals Limited — Dividend/Bonus, 27-12-2024: Stock split

The Board has approved a split of each equity share from a face value of ₹10 into five shares of ₹2 each, subject to shareholder approval via Postal Ballot. This move aims to make shares more accessible and attractive to a broader range of investors, potentially enhancing market liquidity. Post-split, the authorized and paid-up capital will remain at ₹80 Cr, with the number of paid-up shares increasing from 5.87 Cr to 29.35 Cr. The Record Date for determining eligibility will be announced later, with completion expected within two months post-approval.